Gilead Sciences, Inc. GILD
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$167.09$176.58
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
--
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.83% | 10.20% | 4.39% | 4.69% | 2.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.83% | 10.18% | 4.39% | 4.70% | 2.97% |
| Cost of Revenue | 0.06% | 5.20% | -6.17% | 2.47% | -0.32% |
| Gross Profit | 8.55% | 11.52% | 7.57% | 5.29% | 3.84% |
| SG&A Expenses | 18.93% | 40.35% | 16.69% | -4.51% | -4.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.29% | 20.10% | 3.05% | -1.80% | -2.61% |
| Operating Income | 0.23% | -5.23% | 6.55% | 17.77% | 10.64% |
| Income Before Tax | -15.87% | -522.32% | 56.46% | -4.15% | 280.86% |
| Income Tax Expenses | 7.64% | -48.29% | 67.37% | -127.27% | 298.32% |
| Earnings from Continuing Operations | -20.41% | -635.51% | 53.69% | 22.43% | 143.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.41% | -635.51% | 53.69% | 22.43% | 143.58% |
| EBIT | 0.23% | -5.23% | 6.55% | 17.77% | 10.64% |
| EBITDA | 1.48% | -3.98% | 4.94% | 13.75% | 8.64% |
| EPS Basic | -20.35% | -636.37% | 54.18% | 23.02% | 144.36% |
| Normalized Basic EPS | -1.65% | -6.04% | 7.95% | 19.44% | 12.38% |
| EPS Diluted | -20.16% | -641.67% | 54.81% | 23.42% | 143.00% |
| Normalized Diluted EPS | -1.50% | -5.29% | 8.04% | 19.43% | 12.03% |
| Average Basic Shares Outstanding | -0.08% | -0.16% | -0.32% | -0.48% | -0.32% |
| Average Diluted Shares Outstanding | -0.24% | -0.96% | -0.40% | -0.48% | 0.00% |
| Dividend Per Share | 3.80% | 3.80% | 3.80% | 2.60% | 2.60% |
| Payout Ratio | 0.30% | -1.19% | -0.33% | -0.17% | -0.58% |